Watch: Pfizer says vaccine data for younger children delayed

Pfizer and BioNTech are testing a third dose of their Covid-19 vaccine in an ongoing trial of children ages 6 months to under 5 years after the companies found that the two-dose regimen didn’t generate a strong enough immune response in some children, the companies announced Friday.

Follow us or log on to WWW.AF24NEWS.COM for more news.

Latest news
Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here